Abstract
During the past decades, an increasing number of ion channel and transporter types have been identified acting together to produce cardiac and neuronal pacemaker action potentials. The basis of pacemaker activity was understood in more detail by using single-microelectrode recordings on cells isolated from pacemaker regions. Meanwhile, this powerful technique was complemented by computer modeling and recombinant technologies, including gene inactivation of ion channels and transporters, which may be involved in the generation of the electrical activity of pacemaker cells. Several genes of the voltage-gated Ca2+ channel (VGCC) family have been ablated, and their role in cardiac and neuronal pacemaking is compared in the present summary, focusing on the role of murine R-type voltage-gated Ca2+ channels encoded by cacna1e and expressing the ion conducting subunit Cav2.3.
Keywords: Voltage-gated Ca2+ channels, pharmacoresistant R-type, SUDEP, epilepsy, sleep, atrial conduction.
Current Molecular Pharmacology
Title:R-Type Voltage-Gated Ca2+ Channels in Cardiac and Neuronal Rhythmogenesis
Volume: 8
Author(s): Schneider T., Dibue-Adjei M., Neumaier F., Akhtar I., Hescheler J., Kamp M.A. and Tevoufouet E.E.
Affiliation:
Keywords: Voltage-gated Ca2+ channels, pharmacoresistant R-type, SUDEP, epilepsy, sleep, atrial conduction.
Abstract: During the past decades, an increasing number of ion channel and transporter types have been identified acting together to produce cardiac and neuronal pacemaker action potentials. The basis of pacemaker activity was understood in more detail by using single-microelectrode recordings on cells isolated from pacemaker regions. Meanwhile, this powerful technique was complemented by computer modeling and recombinant technologies, including gene inactivation of ion channels and transporters, which may be involved in the generation of the electrical activity of pacemaker cells. Several genes of the voltage-gated Ca2+ channel (VGCC) family have been ablated, and their role in cardiac and neuronal pacemaking is compared in the present summary, focusing on the role of murine R-type voltage-gated Ca2+ channels encoded by cacna1e and expressing the ion conducting subunit Cav2.3.
Export Options
About this article
Cite this article as:
T. Schneider, M. Dibue-Adjei, F. Neumaier, I. Akhtar, J. Hescheler, M.A. Kamp and E.E. Tevoufouet, R-Type Voltage-Gated Ca2+ Channels in Cardiac and Neuronal Rhythmogenesis, Current Molecular Pharmacology 2015; 8 (1) . https://dx.doi.org/10.2174/1874467208666150507093845
DOI https://dx.doi.org/10.2174/1874467208666150507093845 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
Call for Papers in Thematic Issues
Common mechanisms underpinning neurodevelopmental disorders and psychiatric diseases
A growing number of large-scale epidemiologic studies has strongly suggested that common mechanisms may be shared by aberrant brain development and psychiatric disorders. There is now an appreciation of synergic roles of genetic variants and environmental stress which profoundly affect the genome integrity and reshape brain development. This can lead ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Cytokines for Morphine Tolerance: A Narrative Review
Current Neuropharmacology Hippocampal Morphology and Autobiographic Memory in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Herbal Medicine in the Treatment of Epilepsy
Current Drug Targets The Evolution of Histamine H3 Antagonists/Inverse Agonists
Current Topics in Medicinal Chemistry Choline Nutrition Programs Brain Development Via DNA and Histone Methylation
Central Nervous System Agents in Medicinal Chemistry Drug-Resistant Epilepsy and Surgery
Current Neuropharmacology Editorial [ Role of Ion Channels in Neurological Disorders Guest Editor: Johannes J. Krupp ]
CNS & Neurological Disorders - Drug Targets The Potential Clinical Properties of Magnesium
Current Medicinal Chemistry PDZ Domain-mediated Protein Interactions: Therapeutic Targets in Neurological Disorders
Current Medicinal Chemistry Comparative Anatomy, Physiology and In Vitro Models of the Blood-Brain and Blood-Retina Barrier
Current Medicinal Chemistry - Central Nervous System Agents Early Prediction of Preeclampsia: Hope for Early Intervention?
Current Women`s Health Reviews Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design Nanotechnological Advances in the Treatment of Epilepsy
CNS & Neurological Disorders - Drug Targets Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Histone Variants and Composition in the Developing Brain: Should MeCP2 Care?
Current Topics in Medicinal Chemistry Neuropsychiatric Involvement in Systemic Lupus Erythematosus:Current Therapeutic Approach
Current Pharmaceutical Design Drug Targets of Migraine and Neuropathy: Treatment of Hyperexcitability
CNS & Neurological Disorders - Drug Targets Effect of Hemodialysis on Pharmacokinetics of Ezogabine/Retigabine and its N-Acetyl Metabolite in Patients with End Stage Renal Disease
Current Clinical Pharmacology (Section B: Integrated Function of Drug Transporters In Vivo) Drug Transport at the Blood-Brain Barrier and the Choroid Plexus
Current Drug Metabolism Machine Learning, Molecular Modeling, and QSAR Studies on Natural Products Against Alzheimer’s Disease
Current Medicinal Chemistry